T cell activation and anti-tumor efficacy of anti-LAG-3 antibodies is independent of LAG-3 – MHCII blocking capacity. Issue 2 (December 2015) - Cemerski, Saso; Zhao, Shuxia; Chenard, Melissa; Laskey, Jason; Cui, Long; Shukla, Rinkan; Haines, Brian; Hsieh, Edward; Beaumont, Maribel; Mattson, Jeanine; Blumenschein, Wendy; Hirsch, Heather; et al.